Over 450 Total Lots Up For Auction at Three Locations - CO 05/12, PA 05/15, NY 05/20

Avenda Health receives FDA investigational device exemption for AI-enabled prostate cancer therapy

Press releases may be edited for formatting or style | August 10, 2022 Artificial Intelligence Health IT

Derived from experts at UCLA, Avenda Health was founded with support from a National Cancer Institute grant, which was the catalyst to fund the company's participation in many clinical trials at various prototype stages. The FocalPoint system re-imagines laser ablation, which has been used to treat thousands of patients, enabling prostate cancer treatment outside an MRI under ultrasound guidance in a doctor's office. In each of its technologies, Avenda Health is building a more personalized and targeted standard of care for prostate cancer.


About Avenda Health
stats
DOTmed text ad

Your Trusted Source for Sony Medical Displays, Printers & More!

Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.

stats

Avenda Health is creating a more personalized future of prostate cancer care. Using deep learning, Avenda Health software maps a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. Dedicated to bringing this cutting-edge technology to all practices and physicians treating prostate cancer patients, Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.


SOURCE Avenda Health

Back to HCB News

You Must Be Logged In To Post A Comment